New York State Common Retirement Fund’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,109
| Closed | -$50.9K | – | 3208 |
|
|
2025
Q2 | $50.9K | Hold |
5,109
| – | – | ﹤0.01% | 2942 |
|
|
2025
Q1 | $30.5K | Hold |
5,109
| – | – | ﹤0.01% | 2906 |
|
|
2024
Q4 | $39.2K | Hold |
5,109
| – | – | ﹤0.01% | 2914 |
|
|
2024
Q3 | $52.2K | Sell |
5,109
-6,600
| -56% | -$101K | ﹤0.01% | 2850 |
|
|
2024
Q2 | $174K | Buy |
11,709
+6,512
| +125% | +$93.3K | ﹤0.01% | 2486 |
|
|
2024
Q1 | $70.9K | Sell |
5,197
-12
| -0.2% | -$131 | ﹤0.01% | 2868 |
|
|
2023
Q4 | $57K | Sell |
5,209
-46
| -0.9% | -$456 | ﹤0.01% | 2953 |
|
|
2023
Q3 | $57.5K | Sell |
5,255
-19,903
| -79% | -$255K | ﹤0.01% | 2976 |
|
|
2023
Q2 | $333K | Sell |
25,158
-6,161
| -20% | -$87.8K | ﹤0.01% | 2276 |
|
|
2023
Q1 | $426K | Sell |
31,319
-16,083
| -34% | -$288K | ﹤0.01% | 2252 |
|
|
2022
Q4 | $926K | Buy |
47,402
+5,990
| +14% | +$117K | ﹤0.01% | 2014 |
|
|
2022
Q3 | $789K | Sell |
41,412
-177
| -0.4% | -$4.08K | ﹤0.01% | 2087 |
|
|
2022
Q2 | $857K | Buy |
41,589
+27,502
| +195% | +$653K | ﹤0.01% | 2103 |
|
|
2022
Q1 | $453K | Buy |
14,087
+25
| +0.2% | +$908 | ﹤0.01% | 2448 |
|
|
2021
Q4 | $655K | Sell |
14,062
-42
| -0.3% | -$1.4K | ﹤0.01% | 2298 |
|
|
2021
Q3 | $381K | Sell |
14,104
-3,660
| -21% | -$95.7K | ﹤0.01% | 2617 |
|
|
2021
Q2 | $456K | Buy |
17,764
+4,064
| +30% | +$96.8K | ﹤0.01% | 2648 |
|
|
2021
Q1 | $468K | Buy |
13,700
+4,000
| +41% | +$145K | ﹤0.01% | 2489 |
|
|
2020
Q4 | $328K | Buy |
9,700
+4,800
| +98% | +$127K | ﹤0.01% | 2549 |
|
|
2020
Q3 | $121K | Buy |
+4,900
| New | +$132K | ﹤0.01% | 2844 |
|
Other funds holding ITOS
New York State Common Retirement Fund's ITOS Position: Q3 2025 in Review
New York State Common Retirement Fund sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 5,109 shares — an estimated $50.9K sold.
New York State Common Retirement Fund first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $926K in Q4 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- New York State Common Retirement Fund reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 5,109 iTeos Therapeutics shares in Q3 2025, an estimated $50.9K.
- New York State Common Retirement Fund first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- New York State Common Retirement Fund's iTeos Therapeutics position peaked at $926K in Q4 2022.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.